vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and TheRealReal, Inc. (REAL). Click either name above to swap in a different company.

TheRealReal, Inc. is the larger business by last-quarter revenue ($194.1M vs $121.8M, roughly 1.6× Core Laboratories Inc.). On growth, TheRealReal, Inc. posted the faster year-over-year revenue change (18.3% vs -1.4%). TheRealReal, Inc. produced more free cash flow last quarter ($45.8M vs $517.0K). Over the past eight quarters, TheRealReal, Inc.'s revenue compounded faster (16.2% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

The RealReal, Inc. is an online marketplace for users to buy and sell luxury goods that are authenticated by experts. It has more than 38 million members, and has sold nearly 40 million items as of Sept. 30, 2023.

CLB vs REAL — Head-to-Head

Bigger by revenue
REAL
REAL
1.6× larger
REAL
$194.1M
$121.8M
CLB
Growing faster (revenue YoY)
REAL
REAL
+19.8% gap
REAL
18.3%
-1.4%
CLB
More free cash flow
REAL
REAL
$45.3M more FCF
REAL
$45.8M
$517.0K
CLB
Faster 2-yr revenue CAGR
REAL
REAL
Annualised
REAL
16.2%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
REAL
REAL
Revenue
$121.8M
$194.1M
Net Profit
$5.1M
Gross Margin
74.8%
Operating Margin
1.5%
3.2%
Net Margin
4.2%
Revenue YoY
-1.4%
18.3%
Net Profit YoY
EPS (diluted)
$0.11
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
REAL
REAL
Q1 26
$121.8M
Q4 25
$138.3M
$194.1M
Q3 25
$134.5M
$173.6M
Q2 25
$130.2M
$165.2M
Q1 25
$123.6M
$160.0M
Q4 24
$129.2M
$164.0M
Q3 24
$134.4M
$147.8M
Q2 24
$130.6M
$144.9M
Net Profit
CLB
CLB
REAL
REAL
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$-54.1M
Q2 25
$10.6M
$-11.4M
Q1 25
$-154.0K
$62.4M
Q4 24
$7.4M
Q3 24
$11.7M
$-17.9M
Q2 24
$9.0M
$-16.7M
Gross Margin
CLB
CLB
REAL
REAL
Q1 26
Q4 25
20.8%
74.8%
Q3 25
22.0%
74.3%
Q2 25
20.3%
74.3%
Q1 25
19.5%
75.0%
Q4 24
17.8%
74.4%
Q3 24
20.5%
74.9%
Q2 24
21.2%
74.1%
Operating Margin
CLB
CLB
REAL
REAL
Q1 26
1.5%
Q4 25
11.5%
3.2%
Q3 25
15.6%
-4.3%
Q2 25
11.7%
-6.0%
Q1 25
3.6%
-8.0%
Q4 24
11.0%
-3.1%
Q3 24
14.7%
-9.9%
Q2 24
12.3%
-13.0%
Net Margin
CLB
CLB
REAL
REAL
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
-31.1%
Q2 25
8.2%
-6.9%
Q1 25
-0.1%
39.0%
Q4 24
5.7%
Q3 24
8.7%
-12.1%
Q2 24
6.9%
-11.5%
EPS (diluted)
CLB
CLB
REAL
REAL
Q1 26
$0.11
Q4 25
$0.11
$0.06
Q3 25
$0.30
$-0.49
Q2 25
$0.22
$-0.13
Q1 25
$0.00
$-0.14
Q4 24
$0.15
$-0.57
Q3 24
$0.25
$-0.17
Q2 24
$0.19
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
REAL
REAL
Cash + ST InvestmentsLiquidity on hand
$22.8M
$151.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$-415.5M
Total Assets
$587.7M
$409.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
REAL
REAL
Q1 26
$22.8M
Q4 25
$22.7M
$151.2M
Q3 25
$25.6M
$108.4M
Q2 25
$31.2M
$94.3M
Q1 25
$22.1M
$139.6M
Q4 24
$19.2M
$172.2M
Q3 24
$21.5M
$153.2M
Q2 24
$17.7M
$150.7M
Total Debt
CLB
CLB
REAL
REAL
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
REAL
REAL
Q1 26
$275.1M
Q4 25
$266.0M
$-415.5M
Q3 25
$271.3M
$-385.1M
Q2 25
$261.3M
$-338.2M
Q1 25
$253.4M
$-336.1M
Q4 24
$246.6M
$-407.4M
Q3 24
$250.7M
$-345.4M
Q2 24
$240.3M
$-335.3M
Total Assets
CLB
CLB
REAL
REAL
Q1 26
$587.7M
Q4 25
$584.0M
$409.0M
Q3 25
$591.4M
$366.2M
Q2 25
$602.1M
$349.4M
Q1 25
$591.5M
$400.4M
Q4 24
$585.1M
$423.1M
Q3 24
$600.5M
$406.3M
Q2 24
$597.8M
$407.4M
Debt / Equity
CLB
CLB
REAL
REAL
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
REAL
REAL
Operating Cash FlowLast quarter
$4.0M
$49.5M
Free Cash FlowOCF − Capex
$517.0K
$45.8M
FCF MarginFCF / Revenue
0.4%
23.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
REAL
REAL
Q1 26
$4.0M
Q4 25
$7.9M
$49.5M
Q3 25
$8.5M
$19.3M
Q2 25
$13.9M
$-3.6M
Q1 25
$6.7M
$-28.3M
Q4 24
$20.6M
$28.0M
Q3 24
$13.1M
$9.1M
Q2 24
$17.1M
$-6.8M
Free Cash Flow
CLB
CLB
REAL
REAL
Q1 26
$517.0K
Q4 25
$5.0M
$45.8M
Q3 25
$6.5M
$16.9M
Q2 25
$10.4M
$-11.4M
Q1 25
$3.9M
$-33.0M
Q4 24
$17.4M
$22.9M
Q3 24
$10.4M
$5.0M
Q2 24
$14.3M
$-9.8M
FCF Margin
CLB
CLB
REAL
REAL
Q1 26
0.4%
Q4 25
3.6%
23.6%
Q3 25
4.8%
9.7%
Q2 25
8.0%
-6.9%
Q1 25
3.1%
-20.6%
Q4 24
13.4%
14.0%
Q3 24
7.7%
3.4%
Q2 24
10.9%
-6.7%
Capex Intensity
CLB
CLB
REAL
REAL
Q1 26
Q4 25
2.1%
1.9%
Q3 25
1.5%
1.4%
Q2 25
2.7%
4.7%
Q1 25
2.3%
2.9%
Q4 24
2.5%
3.1%
Q3 24
2.0%
2.7%
Q2 24
2.2%
2.1%
Cash Conversion
CLB
CLB
REAL
REAL
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
-0.45×
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

REAL
REAL

Services$149.0M77%
Products$27.2M14%
Shipping And Handling$17.8M9%

Related Comparisons